Franklin Templeton ETF Trust (HELX)
Management Company · BATS · Series S000067393 · View on SEC EDGAR ↗
Holdings data is not available for this fund yet.
On this page
Fund flows (SEC-reported)
- Last month (Mar 2026)
- +$0
- Quarter ending Mar 2026
- +$1.9M
- Trailing 12 months
- +$7.8M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 61 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Guardant Health Inc | 40131M109 | $1.5M | 6.77 | 15,718 | EC | US |
| NATERA INC | 632307104 | $1.4M | 6.65 | 7,131 | EC | US |
| Krystal Biotech Inc | 501147102 | $1.1M | 5.32 | 4,418 | EC | US |
| United Therapeutics Corporation | 91307C102 | $996K | 4.64 | 1,680 | EC | US |
| Insmed Inc | 457669307 | $970K | 4.52 | 5,932 | EC | US |
| Bridgebio Pharma Inc | 10806X102 | $905K | 4.22 | 12,192 | EC | US |
| Ligand Pharmaceuticals Incorporated | 53220K504 | $757K | 3.53 | 3,794 | EC | US |
| AstraZeneca PLC | — | $729K | 3.40 | 3,695 | EC | GB |
| Adaptive Biotechnologies Corp | 00650F109 | $670K | 3.12 | 48,245 | EC | US |
| Vertex Pharmaceuticals Incorporated | 92532F100 | $641K | 2.99 | 1,435 | EC | US |
| Samsung Biologics Co Ltd | — | $640K | 2.99 | 652 | EC | KR |
| Medpace Holdings Inc. | 58506Q109 | $637K | 2.97 | 1,327 | EC | US |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $578K | 2.69 | 748 | EC | US |
| Corteva Inc | 22052L104 | $578K | 2.69 | 6,904 | EC | US |
| Alnylam Pharmaceuticals Inc. | 02043Q107 | $558K | 2.60 | 1,687 | EC | US |
| Eli Lilly & Co. | 532457108 | $545K | 2.54 | 593 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $447K | 2.09 | 5,957 | EC | US |
| Tempus AI Inc. | 88023B103 | $395K | 1.84 | 8,726 | EC | US |
| BioNTech SE | 09075V102 | $386K | 1.80 | 4,340 | EC | DE |
| Neurocrine Biosciences Inc | 64125C109 | $355K | 1.65 | 2,693 | EC | US |
| Stoke Therapeutics Inc | 86150R107 | $343K | 1.60 | 10,539 | EC | US |
| Twist Bioscience Corporation | 90184D100 | $341K | 1.59 | 7,184 | EC | US |
| Argenx SE | — | $328K | 1.53 | 459 | EC | NL |
| PTC Therapeutics, Inc. | 69366J200 | $317K | 1.48 | 4,652 | EC | US |
| Travere Therapeutics Inc | 89422G107 | $301K | 1.40 | 10,129 | EC | US |
| Charles River Laboratories International, Inc. | 159864107 | $249K | 1.16 | 1,445 | EC | US |
| CRISPR Therapeutics AG | — | $222K | 1.04 | 4,671 | EC | CH |
| Repligen Corporation | 759916109 | $220K | 1.03 | 1,866 | EC | US |
| Veracyte Inc | 92337F107 | $219K | 1.02 | 6,788 | EC | US |
| Praxis Precision Medicines Inc | 74006W207 | $215K | 1.00 | 667 | EC | US |
| GRAIL Inc | 384747101 | $214K | 1.00 | 4,138 | EC | US |
| Sartorius AG | — | $205K | 0.96 | 841 | EP | DE |
| Danaher Corporation | 235851102 | $199K | 0.93 | 1,050 | EC | US |
| Thermo Fisher Scientific Inc | 883556102 | $192K | 0.90 | 391 | EC | US |
| IQVIA Holdings Inc. | 46266C105 | $171K | 0.80 | 1,005 | EC | US |
| BEAM THERAPEUTICS INC | 07373V105 | $168K | 0.78 | 7,036 | EC | US |
| Jazz Pharmaceuticals PLC | — | $159K | 0.74 | 841 | EC | IE |
| Catalyst Pharmaceuticals Inc. | 14888U101 | $158K | 0.74 | 6,375 | EC | US |
| Cadence Design Systems, Inc. | 127387108 | $151K | 0.71 | 545 | EC | US |
| Agilent Technologies Inc. | 00846U101 | $129K | 0.60 | 1,136 | EC | US |
| Caredx Inc | 14167L103 | $129K | 0.60 | 7,429 | EC | US |
| QIAGEN NV | — | $127K | 0.59 | 3,175 | EC | NL |
| AnaptysBio Inc. | 032724106 | $113K | 0.53 | 2,041 | EC | US |
| SAMSUNG EPIS HOLDINGS CO LTD | — | $113K | 0.53 | 350 | EC | KR |
| Tarsus Pharmaceuticals Inc | 87650L103 | $104K | 0.49 | 1,487 | EC | US |
| Ultragenyx Pharmaceuticals Inc | 90400D108 | $100K | 0.47 | 4,765 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $97K | 0.45 | 4,107 | EC | US |
| Axsome Therapeutics Inc. | 05464T104 | $96K | 0.45 | 566 | EC | US |
| GeneDx Holdings Corp | 81663L200 | $90K | 0.42 | 1,409 | EC | US |
| Rhythm Pharmaceuticals Inc | 76243J105 | $85K | 0.39 | 974 | EC | US |
Page 1
of 2
← Previous
Next →
Institutional owners (13F) 8 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,529,544 | 40.48% | 38,272 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $1,350,820 | 35.75% | 33,800 | Shares | June 30, 2026 |
| LPL Financial LLC | $615,622 | 16.29% | 15,404 | Shares | June 30, 2026 |
| OSAIC HOLDINGS, INC. | $125,643 | 3.33% | 3,142 | Shares | June 30, 2026 |
| FRANKLIN RESOURCES INC | $106,907 | 2.83% | 2,675 | Shares | June 30, 2026 |
| HARBOUR INVESTMENTS, INC. | $50,146 | 1.33% | 1,255 | Shares | June 30, 2026 |
| HUNTINGTON NATIONAL BANK | $14 | 0.00% | 1 | Shares | June 30, 2026 |
| JPMORGAN CHASE & CO | $1 | 0.00% | 0 | Shares | June 30, 2026 |
Peer funds
Similar by size
| Fund | AUM |
|---|---|
| ELIL Direxion Shares ETF Trust | $21.5M |
| HDG ProShares Trust | $21.6M |
| PSCD Invesco Exchange-Traded Fund Tr… | $21.7M |
| UXOC First Trust Exchange-Traded Fun… | $21.8M |
| PQAP PGIM Rock ETF Trust | $21.9M |
| MEXX Direxion Shares ETF Trust | $21.4M |
| DTAN EA Series Trust | $21.4M |
| VEMY Virtus ETF Trust II | $21.3M |
| TMNS T. Rowe Price Exchange-Traded F… | $21.2M |
| CFIT Cambria ETF Trust | $21.2M |